Table 3.
The association of risk perception with using all three shielding practices
| Demographic or Disease‐Specific Feature | Unadjusted | Adjusted a | ||
|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |
| Risk perception | ||||
| Strongly agree | 4.86 | 2.89‐8.18 | 4.16 | 2.37‐7.29 |
| Agree | 2.05 | 1.27‐3.29 | 1.97 | 1.17‐3.32 |
| Uncertain/disagree | 1.0 | Ref | 1.0 | Ref |
| Age | 0.99 | 0.99‐1.01 | 1.01 | 0.99‐1.03 |
| Male (vs female) | 0.85 | 0.50‐1.45 | 1.13 | 0.60‐2.12 |
| White (vs non‐white) | 1.32 | 0.70‐2.49 | 1.39 | 0.68‐2.84 |
| Any comorbidities | 1.28 | 0.86‐1.91 | 0.94 | 0.58‐1.52 |
| BMI | 1.02 | 0.98‐1.05 | 1.00 | 0.96‐1.04 |
| Current/prior smoker (vs non‐smoker) | 1.15 | 0.78‐1.69 | 0.97 | 0.61‐4.54 |
| bDMARD (vs no bDMARD) | 1.79 | 1.14‐2.80 | 1.76 | 1.06‐2.90 |
| Glucocorticoid (vs no glucocorticoid) | 1.86 | 1.16‐3.00 | 1.70 | 0.98‐2.96 |
| Patient‐reported disease activity | 0.99 | 0.98‐1.00 | 0.99 | 0.99‐1.01 |
Abbreviations: bDMARD, biologic disease‐modifying antirheumatic drug; BMI, body mass index; CI, confidence interval; OR, odds ratio.
Bold indicates P < 0.05.
a
Adjusted for all covariates.